Amended Current Report Filing (8-k/a)
November 17 2017 - 4:07PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K/A
(Amendment
No. 1)
CURRENT
REPORT
Pursuant
to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): November 17, 2017 (September 28, 2017)
BIOSOLAR,
INC.
(Exact
name of registrant as specified in its charter)
Nevada
|
|
000-54819
|
|
20-4754291
|
(State
or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(IRS
Employer
Identification No.)
|
27936
Lost Canyon Road, Suite 202, Santa Clarita, CA 91387
(Address
of principal executive offices and Zip Code)
Registrant's
telephone number, including area code:
(661) 251-0001
Copies to:
Gregory Sichenzia, Esq.
Marcelle S. Balcombe, Esq.
Sichenzia Ross Friedman Ference LLP
1185 Avenue of the Americas, 37th Floor
New York, New York 10036
Phone: (212) 930-9700
Fax: (212) 930-9725
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instruction A.2. below):
☐
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate
by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act
of 1933 (§230.405 of this chapter) or Rule 12b2 of the Securities Exchange Act of 1934 (§240.12b2 of this chapter).
Emerging
growth company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Explanatory
Note
This
amended current report on Form 8-K is being filed to amend the registrant’s current report on Form 8-K filed on October
3, 2017(the “Original 8-K”). This amendment No.1 to the Original 8-K is being filed solely for the purpose of filing
as Exhibit 10.1 the Exclusive License Agreement dated September 28, 2017, subject of the Original 8-K.
Item
1.01 Entry into a Material Definitive Agreement.
On
September 28, 2017 (the “Effective Date”), BioSolar, Inc. (the “Company”) entered into an Exclusive License
Agreement (the “Agreement”) with North Carolina Agricultural and Technical State University (the “University”)
related to the use of the University’s intellectual property in the Company’s business of developing, producing and
marketing lithium-ion batteries.
Within
thirty (30) days after the Effective Date, the Company shall pay to the University a one-time, non-refundable license fee in the
sum of Fifteen Thousand Dollars (US $15,000.00). Pursuant to the terms of the Agreement, the Company is obligated to pay all costs
of preparing, filing, prosecution, issuance and maintenance related to the patents underlying the intellectual property licensed
by the Company. In addition, the Company is obligated to make certain royalty payments and sub-licensing fees.
Unless
earlier terminated in accordance with the Agreement, the term of the Agreement shall commence on the Effective Date and shall
expire on a country-by-country and licensed product-by-licensed product basis. Notwithstanding the foregoing, the University may,
by written notice to the Company, terminate the Agreement during any April after the one year anniversary of the Effective Date,
if the Company, its affiliates, sublicensees, or any contractors of any of the foregoing have not practiced the invention during
the calendar year which precedes such April.
Item
9.01 Financial Statements and Exhibits.
(d)
Exhibits
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
BIOSOLAR, INC.
|
|
|
Date: November 17, 2017
|
/s/ David Lee
|
|
David Lee
|
|
Chief Executive Officer
|
3